Finally, flow cytometry confirmed that SIGLEC9+ TAMs were more abundant in cervical cancer tissue compared to normal cervical tissue, and high infiltration of SIGLEC9+ TAMs was associated with a poor prognosis in cervical cancer. This evidence concerns the gene SIGLEC9 and cervical carcinoma.